In This Section

Home / Advocate / Access, Payment & Reimbursement Reform

Access, Payment & Reimbursement Reform

ACCC is committed to ensuring that cancer patients have access to the entire continuum of quality cancer care, including access to the most appropriate cancer therapies.

  • ACCC Signs Letter Opposing Proposed Medicare Part B IPI Model

    On Monday, December 10, ACCC and 338 patient, provider, and caregiver groups that are part of the Part B Access for Seniors and Physicians Coalition have sent a letter to Congressional leaders asking them to block the Trump Administration's Medicare Part B international price referencing demo. Chief among concerns are the creation of a "middleman" role to negotiate drug pricing; the demo's international price indexing (IPI) mechanism, and its proposed changes to provider reimbursement.

    Read the full letter here
    . Read coverage of the letter here.

    Posted 12/11/2018

  • ACCC Signs Letter of Support for CLINICAL TREATMENT Act

    On November 26, the Association of Community Cancer Centers (ACCC) joined dozens of cancer care organizations and associations in signing a letter of support for H.R. 6836, the CLINICAL TREATMENT Act. This legislation would ensure that states cover routine care costs of participation in approved clinical trials for Medicaid enrollees with life-threatening conditions. Medicaid is currently the only major payer that is not required by federal law to cover these costs.

    Read the full letter of support for H.R. 6836 here.

    Posted 11/26/2018

Coalition Letters

ACCC joined with 240 signers in the September 12, 2018, Part B Access for Seniors and Physicians (ASP) Coalition letter to Congressional leaders. The coalition letter voices stakeholder concerns over the August 7, 2018, memo from the Centers for Medicare and Medicaid Services (CMS) that rescinds long-standing policy and allows Medicare Advantage (MA) plans to implement step therapy to manage Part B drugs in circumstances where applicable starting in 2019.
Read the Letter


CMS CY 2018 OPPS Final Rule

On November 1, 2017, the Centers for Medicare & Medicaid Services (CMS) issued the calendar year (CY) 2018 Hospital Outpatient Prospective Payment System (OPPS) and Ambulatory Surgical Center (ASC) Payment System final rule with comment period (CMS-1678-FC), which includes updates to the 2018 rates and quality provisions, and other policy changes. The final rule contains significant provisions that reduce payments to hospitals participating in the 340B Drug Pricing Program. Read the rule.

CMS CY 2018 Physician Fee Schedule Final Rule

On November 2, 2017, the Centers for Medicare & Medicaid Services (CMS) released the calendar year 2018 Physician Fee Schedule (PFS) rule. Read the final PFS rule.

Archived Webinar: What You Need to Know about CMS' Final 2018 OPPS & PFS Rules

Legal experts present a one-hour (ACCC members-only) discussion about the Centers for Medicare & Medicaid (CMS) final 2018 OPPS and PFS rules. The agency's proposals under the OPPS will bring significant changes to 2018 payments for 340B hospitals and new outpatient facilities. ACCC members can access the recorded webinar, presentation slides, and rule summaries  for in-depth analysis of the final rule. [Login RequiredWebinar originally presented on November 29, 2017.

Quality Payment Program (QPP)


Inpatient Prospective Payment System

  • ACCC analysis of 2018 Inpatient Prospective Payment System (IPPS) final rule. Log in required.

Archive of ACCC Comment Letters on CMS Physician Fee Schedule:

Archive of ACCC Comment Letters to CMS on Recent OPPS Proposed Rules: